ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,859 | -60.7% | 435 | -78.0% | 0.07% | -55.0% |
| Q1 2021 | $544,000 | +22.0% | 1,976 | +30.4% | 0.15% | +16.2% |
| Q4 2020 | $446,000 | +25.3% | 1,515 | +11.6% | 0.13% | +9.2% |
| Q3 2020 | $356,000 | +15.2% | 1,357 | -1.2% | 0.12% | +3.5% |
| Q2 2020 | $309,000 | +38.6% | 1,373 | -1.0% | 0.12% | +64.3% |
| Q4 2019 | $223,000 | – | 1,387 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |